Dehydro-3-epiandrosterone: Difference between revisions
Jump to navigation
Jump to search
m Bot: Automated text replacement (-{{SIB}} + & -{{EH}} + & -{{EJ}} + & -{{Editor Help}} + & -{{Editor Join}} +) |
|||
Line 16: | Line 16: | ||
{{CMG}} | {{CMG}} | ||
==Overview== | ==Overview== | ||
Line 47: | Line 47: | ||
== For Patients == | == For Patients == | ||
[[Category:Blood tests]] | [[Category:Blood tests]] |
Revision as of 00:33, 9 August 2012
Dehydro-3-epiandrosterone |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
- Dehydro-3-epiandrosterone (DHEA) is the main secretory product of the suprarenal cortex. The physiologic significance of DHEA is unclear.
Differential Diagnosis
Decreased
Increased
- Adrenal cortex tumors
- Adrenogenital Syndrome
- Androgen-producing tumor
- Hirsutism
- Hyperprolactinemia
- Ovarian cancer
- Polycystic ovaries [1] [2]
References
Acknowledgements
The content on this page was first contributed by Editor-In-Chief: C. Michael Gibson, M.S., M.D. [2]
List of contributors: